Bevacizumab in combination with paclitaxel for HER-2 negative metastatic breast cancer: an economic evaluation (Q83194112)

From Wikidata
Jump to navigation Jump to search
scientific article published on 13 January 2009
edit
Language Label Description Also known as
English
Bevacizumab in combination with paclitaxel for HER-2 negative metastatic breast cancer: an economic evaluation
scientific article published on 13 January 2009

    Statements

    Bevacizumab in combination with paclitaxel for HER-2 negative metastatic breast cancer: an economic evaluation (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit